Page last updated: 2024-08-24

imiquimod and Pyoderma Gangrenosum

imiquimod has been researched along with Pyoderma Gangrenosum in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Boehncke, WH; Borowczyk-Michalowska, J; Brembilla, NC; Conrad, C; Fallon, PG; Kavanagh, RD; Kaya, G; Mylonas, A; Senra, L; Wrobel, LJ; Yawalkar, N	1

Other Studies

1 other study(ies) available for imiquimod and Pyoderma Gangrenosum

Article	Year
IL-17E (IL-25) Enhances Innate Immune Responses during Skin Inflammation. The Journal of investigative dermatology, 2019, Volume: 139, Issue:8 Topics: Acute Generalized Exanthematous Pustulosis; Adjuvants, Immunologic; Animals; Dermatitis; Disease Models, Animal; Female; Humans; Imiquimod; Immunity, Innate; Interleukin-17; Interleukins; Macrophages; Mice; Mice, Knockout; Neutrophils; p38 Mitogen-Activated Protein Kinases; Pyoderma Gangrenosum; Skin; Up-Regulation	2019

Article

Year

IL-17E (IL-25) Enhances Innate Immune Responses during Skin Inflammation.

The Journal of investigative dermatology, 2019, Volume: 139, Issue:8

Topics: Acute Generalized Exanthematous Pustulosis; Adjuvants, Immunologic; Animals; Dermatitis; Disease Models, Animal; Female; Humans; Imiquimod; Immunity, Innate; Interleukin-17; Interleukins; Macrophages; Mice; Mice, Knockout; Neutrophils; p38 Mitogen-Activated Protein Kinases; Pyoderma Gangrenosum; Skin; Up-Regulation

2019